Rimantadine is an amantadine derivative with pronounced antiviral properties.
Remantadīns® is efficient against type A influenza viruses. Rimantadine has no or only minor effect against type B influenza viruses. Rimantadine inhibit virus replication at the early stage of the cycle, probably, by inhibiting the development of viral envelope.
Adults and children aged 10 and over:
100 mg twice per day, for people over 60 years of age – 100 mg once per day.
The duration of the therapy course is 5 days. For prevention, the use of the medication should be commenced at the time of the outbreak of an influenza epidemic, the use must be continued during the epidemic, but no longer than for 2 weeks.
Not recommended for use in children under 10 years of age.